Abstract
Chronic heart failure (CHF) is a modern-day epidemic in most developed countries. As such, it is both common and costly. Contrary to the impression given by clinical trial data, CHF mainly affects older individuals with approximately equal numbers of men and women and concurrent disease profiles likely to complicate or even prohibit the application of proven treatments. It is within this context that there has been an increasing interest in specific CHF-management programmes designed to limit costly hospital use in typically older individuals at high risk for poor quality of life, recurrent readmissions and premature death. This paper examines the evidence to suggest that CHF programmes involving individualised multidisciplinary post-discharge healthcare, with a major focus on specialist nurse management to ensure that the patient receives optimal treatment, are clinically and economically effective in reducing the typical burden imposed by CHF.
These programmes appear to be most effective in ‘high-risk’ patients who typically have recurrent readmissions in high-cost units. Overall, the literature suggests that these programmes are able to reduce recurrent hospital stay by 30–50% relative to usual care (even in the presence of gold-standard treatment) in the short to medium term with comparable cost benefits. Recent data from a management programme involving a cohort of typically older and fragile patients with CHF in Australia showed that at 3 years post index admission, hospital utilisation costs were reduced by one-third relative to usual care. The potential for enormous cost benefits (both in terms of absolute cost savings and in terms of facilitating a more efficient healthcare system) if a specialist nurse programme of care was applied in the form of a UK-wide heart failure service was also recently examined. Based on year 2000 activity levels, it was found that for each specialist heart failure nurse appointed in the UK (with a caseload of 200–250 patients per annum), nominal savings of £49 000 per annum could be generated in order to make the healthcare system more efficient.
Similar content being viewed by others
References
Garg R, Packer M, Pitt B, et al. Heart failure in the 1990’s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol 1993; 22: 3A–5A
Adams KF. New epidemiologic perspectives concerning mild-to-moderate heart failure. Am J Med 2001; 110 Suppl 7A: 6S–13S
Capewell S, MacIntyre K, Stewart S, et al. Age, sex and social trends in out-of-hospital cardiac deaths in Scotland 1986–1995: a retrospective cohort study. Lancet 2001; 358: 1213–7
Capewell S, Livingston BM, MacIntyre K, et al. Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 2000; 21: 1833–40
Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA Project populations. Lancet 1999; 353: 1547–57
MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in case-fatality in 66,547 patients hospitalised between 1986 and 1995. Circulation 2000; 102: 1126–31
Stewart S, MacIntyre K, McCleod MC, et al. Trends in heart failure hospitalisations in Scotland, 1990–1996: an epidemic that has reached its peak? Eur Heart J 2000; 22: 209–17
Stewart S, MacIntyre K, Capewell S, et al. Heart failure and the aging population: an increasing burden in the 21[st] century? Heart 2003; 89: 49–53
Kelly DT. Our future society: a global challenge. Circulation 1997; 95: 2459–64
Bonneux L, Barendregt JJ, Meeter K, et al. Estimating clinical morbidity due to ischaemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994; 84: 20–8
Mosterd A, Reitsma JB, Grobbee DE. ACE inhibition and hospitalisation rates for heart failure in The Netherlands, 1980-1998: the end of an epidemic? Heart 2002; 87: 75–6
Cleland JG, Gemmell I, Khand A, et al. Is the prognosis of heart failure improving? Eur J Heart Fail 1999; 1: 229–41
Haldeman GA, Croft JB, Giles WH, et al. Hospitalization of patients with heart failure: national hospital discharge survey 1985–1995. Am Heart J 1999; 137: 352–60
Eriksson H, Wilhelmsen L, Caidahl K, et al. Epidemiology and prognosis of heart failure. Z Kardiol 1991; 80: 1–6
Doughty R, Yee T, Sharpe N, et al. Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988–91. N Z Med J 1995; 108: 473–5
Reitsma JB, Mosterd A, de Craen AJM, et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980–1993. Heart 1996; 76: 388–92
Rydén-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med 1999; 246: 275–84
McMurray JJV, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 1993; 6: 91–8
Stewart S, Jenkins A, Buchan S, et al. The current cost of heart failure in the UK: an economic analysis. Eur J Heart Fail 2002; 4: 361–71
Petrie MC, Dawson NF, Murdoch DR, et al. Failure of women’s hearts. Circulation 1999; 99: 2334–41
Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002; 162: 1682–8
MacDowall P, Kaira P, O’Donoghue D, et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998; 352: 13–6
Berry C, McMurray J. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone. Am J Med 2001; 111: 587
Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999; 100: 2312–8
CIBIS II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 1999; 353: 9–13
Packer M, Coats AJS, Fowler MB, et al., for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651–8
The RALES Investigators. Effectiveness of spirinolactone added to an angiotensin-converting enzyme inhibitor and a loop-diuretic for severe chronic congestive heart failure. Am J Cardiol 1996; 78: 902–7
CIBIS-II Investigators and Health Economics Group. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second cardiac insufficiency bisoprolol study (CIBIS-II). Eur Heart J 2001; 22: 1021–31
Stewart S, McMurray JJV, Hebborn A, et al. Carvedilol reduces the cost of medical care in severe heart failure: an economic analysis of the COPERNICUS Study applied to the United Kingdom. Circulation 2001; 104: II–717
Hummel S, Piercy J, Wright R, et al. An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Pharmacoeconomics 1997; 12 (2 Pt 1): 182–92
Stewart S, MacIntyre K, Hole DA, et al. More malignant than cancer?: five-year survival following a first admission for heart failure in Scotland? Eur J Heart Fail 2001; 3: 315–22
Cowie MR, Wood DA, Coats AJS, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2001; 83: 505–10
Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002; 87: 235–41
Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002; 23: 842–5
Levenson JW, McCarthy EP, Lynn J, et al. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000; 48: S101–9
Vaccarino V, Kasl SV, Abramson J, et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199–205
Jaagosild P, Dawson NV, Thomas C, et al. Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators: the Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments. Arch Intern Med 1998; 158: 1081–9
Mark DB. Economics of treating heart failure. Am J Cardiol 1997; 80: 33H-8H
Weintraub WS, Cole J, Tooley JF. Cost and cost-effectiveness studies in heart failure research. Am Heart J 2002; 143: 565–76
Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch Intern Med 1999; 159: 1690–700
Ahmed A. Quality and outcomes of heart failure care in older adults: role of multidisciplinary disease-management programmes. J Am Geriatr Soc 2002; 50: 1590–3
McAlister FA, Lawson FM, Teo KK, et al. A systematic review of randomized trials of disease management programmes in heart failure. Am J Med 2001; 110: 378–84
Rich MW. Heart failure disease management: a critical review. J Card Fail 1999; 5: 64–75
Philbin EF. Comprehensive multidisciplinary programmes for the management of patients with congestive heart failure. J Gen Intern Med 1999; 14: 130–5
McMurray JJV, Stewart S. Nurse-led multidisciplinary intervention in chronic heart failure [editorial]. Heart 1998; 80: 430–1
Horowitz JD. Home-based intervention: the next step in treatment of chronic heart failure? Eur Heart J 2000; 21: 1807–9
Erhardt L, Cline C. Heart failure clinics: a possible means of improving care. Heart 1998; 80: 428–9
Cline CM, Boman K, Holst M, et al. The management of heart failure in Sweden. Eur J Heart Fail 2002; 4: 373–6
Rich MW, Vinson JM, Sperry JC, et al. Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study. J Gen Intern Med 1993; 8: 585–90
Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190–5
Cintron G, Bigas C, Linares E, et al. Nurse practitioner role in a chronic congestive heart failure clinic: in hospital time, costs and patient satisfaction. Heart Lung 1993; 12: 237–40
Naylor M, Brooten D, Jones R, et al. Comprehensive discharge planning for the hospitalized elderly. Ann Intern Med 1994; 120: 999–1006
Fitzgerald JF, Smith DM, Martin DK, et al. A case manager intervention to reduce readmissions. Arch Intern Med 1994; 154: 1721–9
Kornowski R, Zeeli D, Averbuch M, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995; 129: 162–6
Lasater M. The effect of a nurse managed CHF clinic on patient readmission and length of stay. Home Healthc Nurse 1996; 14: 351–6
Roglieri J, Futterman R, McDonough KL, et al. Disease management interventions to improve outcomes in congestive heart failure. Am J Manag Care 1997; 3: 1831–9
Hanumanthu S, Butler J, Chomsky D, et al. Effect of a heart failure programme on hospitalization frequency and exercise tolerance. Circulation 1997; 96: 2842–8
West J, Miller N, Parker K, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997; 79: 58–63
Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management programme on hospital readmissions and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997; 30: 725–32
Shah NB, Der E, Ruggerio C, et al. Prevention of hospitalizations for heart failure with an interactive home monitoring programme. Am Heart J 1998; 135: 373–8
Macko MJ. Evaluation of cost and hospitalization outcomes from a community case management programme serving heart failure clients [Abstract]. J Card Fail 1998; 4: 59
Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with chronic congestive heart failure. Arch Intern Med 1998; 158: 1067–72
Cline C, Israelsson B, Willenheimer R, et al. A cost effective management programme for heart failure reduces hospitalization. Heart 1998; 80: 442–6
Ekman I, Andersson B, Ehnfors M, et al. Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J 1998; 19: 1254–60
Oddone EZ, Weinberger M, Giobbie-Hurder A, et al. Enhanced access to primary care for patients with congestive heart failure: Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. Eff Clin Pract 1999; 2: 201–9
Cordisco ME, Beniaminovitz A, Hammond K, et al. Use of telemonitoring to decrease the rate of hospitalization in patients with severe congestive heart failure. Am J Cardiol 1999; 84: 860–2
Stewart S, Vandenbroek A, Pearson S, et al. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among congestive heart failure patients. Arch Intern Med 1999; 159: 257–61
Gattis WA, Hasselblad V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999; 159: 1939–45
Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomized controlled study. Lancet 1999; 354: 1077–83
Jaarsma T, Halfens R, Huijer Abu-Saad H, et al. Effects of education and support on self-care and resource utilization in patients with heart failure. Eur Heart J 1999; 20: 673–82
Naylor MD, Brooten D, Cambell R, et al. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA 1999; 281: 613–20
Dahl J, Penque S. The effects of an advanced practice nurse-directed heart failure programme. Nurse Pract 2000; 25: 61–77
Moser DK, Macko MJ, Worster P. Community case management decreases rehospitalisation rates and costs, and improves quality of life in heart failure patients with preserved and non-preserved left ventricular function: a randomized controlled trial. Circulation 2000; 102: II 749
Jerant AF, Azari R, Nesbitt TS. Reducing the cost of frequent hospital admissions for congestive heart failure: a randomized trial of a home telecare intervention. Med Care 2001; 39: 1234–45
McDonald K, Ledwidge M, Cahill J, et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge. Eur J Heart Fail 2001; 3: 209–15
Holst DP, Kaye D, Richardson M, et al. Improved outcomes from a comprehensive management system for heart failure. Eur J Heart Fail 2001; 3: 619–25
Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol 2002; 39: 471–80
Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 2002; 105: 2861–6
Riegel B, Carlson B, Kopp Z, et al. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 2002; 162: 705–12
Harrison MB, Browne GB, Roberts J. Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition. Med Care 2002; 40: 271–82
Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002; 39: 83–9
Doughty RN, Wright SP, Walsh HJ, et al. Randomised, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. Eur Heart J 2002; 23: 139–46
Blue L, Strong E, Murdoch DR, et al. Improving long-term outcome with specialist nurse intervention in heart failure: a randomized trial. BMJ 2002; 323: 1112–5
Petrie MC, Berry C, Stewart S, et al. Failing ageing hearts. Eur Heart J 2001; 22: 1978–90
Wolinsky F, Smith D, Stump T, et al. The sequele of hospitalization for congestive heart failure among older adults. J Am Geriatr Soc 1997; 45: 558–63
Burns RB, McCarthy EP, Moskowitz MA, et al. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 1997; 45: 276–80
Stewart S, Pearson S, Luke CG, et al. Effects of a home based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998; 46: 174–80
Swedberg K, Kjekshus J, Snapinn S, et al. Long-term survival in severe heart failure in patients with enalapril. Eur Heart J 1999; 20: 136–9
Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996; 101: 270–6
Cline CM, Bjorck-Linne AK, Israelsson BY, et al. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999; 1: 145–9
Jaarsma T, Dracup K. Determinants of health care utilization by patients with chronic heart failure. In: Stewart S, Blue L, editors. Improving outcomes in chronic heart failure. London: BMJ Books, 2000
McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441–6
Stewart S, Hart CL, Hole DJ, et al. The incidence and natural history of heart failure in 15,406 men and women over 20 years: the Renfrew/Paisley Study. Eur Heart J 2001; 22: 208
Stewart S, Blue L, Walker A, et al. An economic analysis of specialist heart failure nurse management in the UK: can we afford not to implement it? Eur Heart J 2002; 23: 1369–75
Blue L, McMurray JJV. A specialist, nurse-led, home-based intervention in Scotland. In: Stewart S, Blue L, editors. Improving outcomes in chronic heart failure. London: BMJ Books, 2000
Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001; 22: 1527–60
UK National Health Service. National Health Service (UK) reference costs (2000). Available from URL: http://www.doh.gov.uk/nhsexec/refcosts/2000 [Accessed 2001 Jul]
Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948–55
Senni M, Redfield MM. Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 2001; 38: 1277–82
Acknowledgements
The National Heart Foundation (NHF) of Australia and the National Health and Medical Research Council of Australia (NH&MRC) support Professor Simon Stewart. The authors have no conflicts of interest directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stewart, S., Horowitz, J.D. Specialist Nurse Management Programmes. Pharmacoeconomics 21, 225–240 (2003). https://doi.org/10.2165/00019053-200321040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200321040-00001